# US 2019/0054213 A1 · Antimicrobial Medical Devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0054213 A1
- Document ID: US20190054213A1
- Status: Published application
- Kind: A1
- Application number: 16/104,442
- Filed: 2018-08-17
- Published: 2019-02-21
- Earliest claimed: 2017-08-18
- Assignees: Becton, Dickinson and Company
- Applicants: Becton, Dickinson and Company
- Inventors: Theresa Hermel-Davidock; Tea Datashvili
- Web page: https://patentgrep.com/patent/US20190054213A1

## CPC

- A61L 29/041: {obtained by reactions only involving carbon-to-carbon unsaturated bonds}
- A01N 25/10: Macromolecular compounds
- A01N 43/40: six-membered rings
- A01N 43/90: having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
- A01N 59/16: Heavy metals; Compounds thereof
- A01N 59/20: Copper
- A61K 31/44: Non condensed pyridines; Hydrogenated derivatives thereof
- A61K 31/4745: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines (yohimbine derivatives, vinblastine A61K31/475; ergoline derivatives A61K31/48)
- A61K 33/34: Copper; Compounds thereof
- A61K 33/38: Silver; Compounds thereof
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- C08F 210/06: Propene
- C08F 255/02: on to polymers of olefins having two or three carbon atoms
- C08L 23/12: Polypropene
- C08L 51/06: grafted on to homopolymers or copolymers of aliphatic hydrocarbons containing only one carbon-to-carbon double bond
- C09C 1/30: Silicic acid
- C09C 1/309: {Combinations of treatments provided for in groups C09C1/3009 - C09C1/3081}
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- C09C: TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES (treatment of materials specially adapted to enhance their filling properties in mortars, concrete or artificial stone C04B14/00, C04B18/00, C04B20/00); PREPARATION OF CARBON BLACK {; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS}

## Abstract

Medical devices comprise a polymeric body comprising: a base polymeric formulation comprising at least a polymer or co-polymer of propylene; and an additive comprising a copolymer having a polypropylene backbone and hybrid micromolecule side-chains based on organo-functional silanes (PP-g-XSiOA) in the presence of a co-agent, for example, difunctional metallic diacrylate monomers, where “X” is an organic group or an organo-functional group, and “A” is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material. X may be derived from a compound selected from the group consisting of epoxy, amino, acrylate, methacryloxy, and vinyl; and A is selected from the group consisting of: silicon, (Si), aluminum (Al), iron (Fe), titanium (Ti), silver (Ag), zinc (Zn), nickel (Ni), calcium (Ca), copper (Cu), tin (Sn); oxides thereof; hydroxides thereof; and mixtures of the foregoing. Antimicrobial agents are included in the polymeric body. The medical devices have enhanced antimicrobial properties.

## Claims

### Claim 1

A medical device comprising:
a polymeric body comprising:
a base polymeric formulation comprising at least a polymer or co-polymer of propylene; and
an additive comprising a copolymer having a polypropylene backbone and hybrid micromolecule side-chains based on organo-functional silanes (PP-g-XSiOA), where “X” is an organic group or an organo-functional group; and “A” is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material;
the PP-g-XSiOA being in a blend with the base polymeric formulation in an amount in the range of about 0.01 to about 20.0% by weight of the blend; and
an antimicrobial agent.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein the antimicrobial agent comprises: berberine chloride, berberine chloride hydrate, octinedine dihydrochloride, 4-chlorophenyl methyl sulfone, climbazole, piroctone olamine, silver sulfadiazine, copper particles, silver particles, or combinations thereof.

### Claim 3 (depends on 2)

The medical device of claim 2, wherein the antimicrobial agent is present in an amount in the range of 0.02 to 3% by weight of the blend of additive and base polymeric formulation.

### Claim 4 (depends on 1)

The medical device of claim 1, wherein the PP-g-XSiOA is according to Formula (I):
wherein X is an organic group or an organo-functional group; A is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material; and “n” is in the range of about 78 to 99.9 mole percent; m is in the range of about 0.1 to 20 mole percent; the molar value of “y” is in the range of about 0 to 2.0 mole percent; and “Z”, when y is greater than 0, comprises: M-X2; XSiOR; or XSiOH, wherein “M-X2” is an organo-metal salt and “OR” is an alkoxy group having 1 to 4 carbons.

### Claim 5 (depends on 1)

The medical device of claim 1, wherein the base polymeric formulation comprises polypropylene, a polyethylene-polypropylene co-polymer, a polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof.

### Claim 6 (depends on 1)

The medical device of claim 1, wherein X of the PP-g-XSiOA is derived from a compound selected from the group consisting of epoxy, amino, acrylate, methacryloxy, and vinyl; and A is selected from the group consisting of: silicon, (Si), aluminum (Al), iron (Fe), titanium (Ti), silver (Ag), zinc (Zn), nickel (Ni), calcium (Ca), copper (Cu), tin (Sn); oxides thereof; hydroxides thereof; and mixtures of the foregoing.

### Claim 7 (depends on 1)

The medical device of claim 1, wherein the PP-g-XSiOA has a melting point in the range of 140 to 180° C.

### Claim 8 (depends on 1)

The medical device of claim 1, wherein the PP-g-XSiOA has a capillary viscosity in the range of 100 to 300 Pa·s at 180 s−1.

### Claim 9 (depends on 1)

The medical device of claim 1, wherein the PP-g-XSiOA has a weight average molecular weight (Mw) in the range of about 100,000 to about 350,000 g/mol.

### Claim 10 (depends on 1)

The medical device of claim 1, wherein the PP-g-XSiOA has a dispersity index in the range of 1.5 to 9.

### Claim 11 (depends on 1)

The medical device of claim 1, wherein the PP-g-XSiOA has a long chain branching frequency in the range of 0.007 to 0.017 per 1000 carbon.

### Claim 12 (depends on 1)

The medical device of claim 1, wherein the PP-g-XSiOA has a melt flow rate in the range of 15 to 55 g/10 minutes.

### Claim 13 (depends on 1)

The medical device of claim 1 in the form of tubing, barrel, rod, or any other geometric shape.

### Claim 14

A method of making a medical device comprising:
obtaining a copolymer having a polypropylene backbone and hybrid micromolecule side-chains based on organo-functional silanes (PP-g-XSiOA), where “X” is an organic group or an organo-functional group; and “A” is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material;
combining the PP-g-XSiOA with a base polymeric formulation comprising at least a polymer or co-polymer of propylene to form a blend, the PP-g-XSiOA being present in the blend in an amount in the range of about 0.01 to about 20.0% by weight of the blend;
adding an antimicrobial agent to the blend to form a mixture; and
forming a polymeric body from the mixture.

### Claim 15 (depends on 14)

The method of claim 14, wherein the antimicrobial agent comprises: berberine chloride, berberine chloride hydrate, octinedine dihydrochloride, 4-chlorophenyl methyl sulfone, climbazole, piroctone olamine, silver sulfadiazine, copper particles, silver particles, or combinations thereof.

### Claim 16 (depends on 14)

The method of claim 14, wherein the base polymeric formulation comprises polypropylene, a polyethylene-polypropylene co-polymer, a polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof.

### Claim 17 (depends on 14)

The method of claim 14, wherein the PP-g-XSiOA is according to Formula (I):
wherein X is an organic group or an organo-functional group; A is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material; and “n” is in the range of about 78 to 99.9 mole percent; m is in the range of about 0.1 to 20 mole percent; the molar value of “y” is in the range of about 0 to 2.0 mole percent; and “Z”, when y is greater than 0, comprises: M-X2; XSiOR; or XSiOH, wherein “M-X2” is an organo-metal salt and “OR” is an alkoxy group having 1 to 4 carbons.

### Claim 18 (depends on 17)

The method of claim 17, wherein X of the PP-g-XSiOA is derived from a compound selected from the group consisting of epoxy, amino, acrylate, methacryloxy, and vinyl; and A is selected from the group consisting of: silicon, (Si), aluminum (Al), iron (Fe), titanium (Ti), silver (Ag), zinc (Zn), nickel (Ni), calcium (Ca), copper (Cu), tin (Sn); oxides thereof; hydroxides thereof; and mixtures of the foregoing.

### Claim 19 (depends on 14)

The method of claim 14, wherein the medical device is in the form of tubing, barrel, rod, or any other geometric shape.
